219 related articles for article (PubMed ID: 9733595)
1. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
[TBL] [Abstract][Full Text] [Related]
2. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts.
Huynh TT; Iaccarino G; Davies MG; Svendsen E; Koch WJ; Hagen PO
Surgery; 1998 Aug; 124(2):177-86. PubMed ID: 9706136
[TBL] [Abstract][Full Text] [Related]
4. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
5. The temporal sequence of G-protein expression in intimal hyperplasia.
Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
[TBL] [Abstract][Full Text] [Related]
6. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
[TBL] [Abstract][Full Text] [Related]
10. Reduction of experimental vein graft intimal hyperplasia by ketanserin.
Massey MF; Davies MG; Svendsen E; Klyachkin ML; Schwartz LB; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 Jun; 54(6):530-8. PubMed ID: 8412062
[TBL] [Abstract][Full Text] [Related]
11. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
[TBL] [Abstract][Full Text] [Related]
13. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
[TBL] [Abstract][Full Text] [Related]
14. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts.
Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
J Surg Res; 1994 Jul; 57(1):106-21. PubMed ID: 8041125
[TBL] [Abstract][Full Text] [Related]
15. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
[TBL] [Abstract][Full Text] [Related]
16. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
Saunders PC; Pintucci G; Bizekis CS; Sharony R; Hyman KM; Saponara F; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
J Thorac Cardiovasc Surg; 2004 May; 127(5):1276-84. PubMed ID: 15115983
[TBL] [Abstract][Full Text] [Related]
17. [Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts].
Li Q; Zhang K; Jiang X; Sun T; Wu L; Zhou C; Chen S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):354-8. PubMed ID: 18396721
[TBL] [Abstract][Full Text] [Related]
18. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
[TBL] [Abstract][Full Text] [Related]
19. Influence of perioperative catheter injury on the long-term vein graft function and morphology.
Davies MG; Dalen H; Svendsen E; Hagen PO
J Surg Res; 1996 Dec; 66(2):109-14. PubMed ID: 9024820
[TBL] [Abstract][Full Text] [Related]
20. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
